T-cell cytokine-inducing surface molecules and methods of use
Details for Australian Patent Application No. 2008261030 (hide)
International Classifications
Event Publications
28 January 2010 PCT application entered the National Phase
PCT publication WO2008/151307 Priority application(s): WO2008/151307
13 January 2011 Assignment before Grant
The Regents of the University of Colorado The application has been assigned to Western States Biopharmaceuticals, Inc.
14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008261042-Expression of soluble antibody fragment by truncation of CH1 domain
2008261027-Selective inhibitors for cyclin-dependent kinases
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser